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Background: Endothelial dysfunction after drug eluting stent (DES) implantation is considered to be partly associated with late stent thrombosis. 
However coronary endothelial function after 2nd generation DESs implantation has not been well examined.
Methods: 18 coronary vessels of 7 Yorkshire pigs were randomly allocated to 2 groups and Nobori or Xience V stents (n=9 vessels/each) were 
implanted. One month after stent implantation, all animals underwent repeat angiogram and in-vivo vasomotor function test following euthanasia for 
ex-vivo endothelial function test, histology and microarray gene analysis.
Results: One month after stent implantation, Nobori stents showed better results in QCA and histology as compared to Xience V (Table). After 
intracoronary acetylcholine injection, 4 vessels for Nobori (44%) and 9 vessels for Xience V (100%) showed vasoconstriction in stented distal 
segments (p=0.031). However there is no significant difference in %diameter change as well as ex-vivo endothelial function between 2 groups. 
Microarray analysis of stented vessel tissue revealed that the gene expressions of some cytokines and chemokines involved in inflammatory and 
immune responses were lower in Nobori as compared to Xience V.
Conclusions: Although in-vivo and ex-vivo endothelial function tests showed no difference between 2 groups, with regards to histopathological 
analysis, Nobori stent demonstrated lower inflammatory and immune responses as compared to Xience V in the gene array analysis. 
Nobori® stent Xience V® stent p value
Quantitative Coronary Angiography (QCA)
Minimal Lumen Diameter (mm) 2.29±0.21 1.52±0.49 0.001
Late Lumen Loss (mm) 0.76±0.2 1.22±0.3 0.005
%Diameter Stenosis (%) 21±5 39±13 0.002
Histomorphology
Neointimal Thickness (μm) 113±60 414±218 0.02
Neointimal Area (mm2) 1.21±0.68 3.34±1.70 0.036
%Area Stenosis (%) 21±7 43±18 0.037
Histopatology
Inflammatory Cell Score 1.20±0.45 2.25±0.88 0.051
Mural Injury Score 0.40±0.55 2.08±1.07 0.018
Fibrin Deposition Score 1.27±0.28 2.25±0.50 0.01
In-vivo Vasomotor Function Test Acetylcholine (10-6 M/ml)
%Diameter Change (proximal, %) -8±13 -9±10 0.48
%Diameter Change (distal, %) 0.7±4 -4±3 0.37
Ex-vivo Endothelial Function Test Superoxide Anion (O2-) Production (RLU/s/mg)
Proximal Segments 87.6±62.1 7.5±1.7 0.27
Distal Segments 24.1±11.1 16.9±8.8 0.62
Microarray Pathway Analysis cut off: p<0.05, fold change>2
Genes Downregulated in Nobori as Compared to Xience 
V
MCP-1, TNF, CCR7, IL-1`, IL-2Ra, P-Selectin, L-Selectin, Flk-1, Integrin-`2, Complement 
factor B
Genes Upregulated in Nobori as Compared to Xience V Adiponectin C1q
